Search

everythinglearnresearchcommunity

for

Search:↓

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Wildebeest stress and hormone levels are influenced by food availability, human presence, and reproductive cycles.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Exercise and finasteride together improve ovary health in PCOS rats.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.